1278341

Mark L. Freedman, M.D. — FEI 3035777013

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Toronto (Canada)

Additional Details

Clinical BA/BE